Symmetry Investments’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-7,213
Closed -$513K 206
2023
Q3
$513K Buy
7,213
+816
+13% +$61K 0.1% 118
2023
Q2
$493K Buy
6,397
+1,897
+42% +$147K 0.08% 121
2023
Q1
$338K Buy
+4,500
New +$335K 0.08% 104

Other funds holding CL

Symmetry Investments's CL Position: Q4 2023 in Review

Symmetry Investments sold out of Colgate-Palmolive (CL) in Q4 2023, closing a stake of 7,213 shares — an estimated $513K sold.

Symmetry Investments first reported a position in CL in Q1 2023 and held it in 3 quarters. The position peaked at $513K in Q3 2023. 1,740 funds tracked by Wall St. Rank hold CL as of Q4 2023.

  • Symmetry Investments reported no remaining Colgate-Palmolive position as of Q4 2023 after selling out during the quarter.
  • Symmetry Investments sold 7,213 Colgate-Palmolive shares in Q4 2023, an estimated $513K.
  • Symmetry Investments first reported a position in Colgate-Palmolive in Q1 2023 and held it in 3 quarters.
  • Symmetry Investments's Colgate-Palmolive position peaked at $513K in Q3 2023.
  • 1,740 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2023.

Based on Symmetry Investments's 13F filing for Q4 2023, filed 14 Feb 2024.